U.S. flag An official website of the United States government
  1. Home
  2. Tobacco Products
  3. Tobacco Science & Research
  4. Research
  5. GSU TCORS: Enhancing the Economic Impact Analysis Used in FDA's Rules for Tobacco Products
  1. Tobacco Science & Research

GSU TCORS: Enhancing the Economic Impact Analysis Used in FDA's Rules for Tobacco Products

GSU TCORS: Enhancing the Economic Impact Analysis Used in FDA's Rules for Tobacco Products

Principal Investigator: Frank Chaloupka

Funding Mechanism: National Institutes of Health- TCORS Grant

ID number: 1P50DA036128-01

Award Date: 9/30/2013

Institution: University of Illinois at Chicago


There are numerous challenges inherent in conducting the type of economic impact analysis the U.S. Food and Drug Administration (FDA) uses to inform its regulatory activities. This project will produce new evidence to inform and refine the FDA's economic impact assessments of future proposed rules related to tobacco use. This will be accomplished through a combination of behavioral economics experiments involving original data collection; acquisition of existing archival, survey, and commercial databases; and merged data analyses that address current and emerging issues. Specific aims are: (1) to assess the impact of FDA regulatory actions and other tobacco control policies (e.g., graphic health warnings, point-of-sale marketing restrictions, flavor bans, pack size restrictions) on tobacco use and related outcomes, including the impact on tobacco use trajectories among young people and adults, the differential impact of these actions on disparate populations, and the differential impact on the use of traditional and emerging tobacco products; (2) to assess the impact of FDA regulatory actions and other tobacco control policies on the consumer surplus (i.e., enjoyment) obtained by tobacco users, via a behavioral economics experiment that will quantify the extent of present bias, projection bias and time inconsistencies in decisions about tobacco use and the implications of these biases for assessing changes in consumer surplus; and (3) to extend the range of costs and benefits involved in assessing the economic impact of FDA regulatory actions to include a broader set of health and economic benefits (e.g. benefits related to reductions in secondhand smoke exposure and maternal smoking during and after pregnancy) than that included in previous FDA assessments. This project may produce new evidence to inform the FDA's economic impact assessments of future proposed rules concerning tobacco products.


The Science of Decision Making: Connecting People and Policy (TCORS) Related Resources